BioSpace News Archive

ARYA Sciences Acquisition Corp II (Nasdaq: ARYBU) (the “Company”) announced today that, commencing July 24, 2020, holders of the units sold in the Company’s initial public offering of 14,950,000 units, completed on June 9, 2020, may elect to separately trade the Class A ordinary shares and warrants included in the units.

Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced three upcoming poster presentations at the Alzheimer’s Association International Conference (AAIC) 2020.

Today, The Get the Medications Right™ (GTMRx) Institute, a catalyst for change that brings critical stakeholders together who are bound by the urgent need to get the medications right, is announcing the launch of “The GTMRx Blueprint for Change,”

G1 Therapeutics, Inc. (Nasdaq: GTHX), a clinical-stage oncology company, today announced a license agreement for lerociclib to EQRx™, a biopharmaceutical company focused on making innovative medicines at dramatically lower prices for the benefit of people and society.

- Hyundai and its dealers have donated over $172 million to pediatric cancer research since 1998 - HHOW names new National Youth Ambassadors - Alex Ferm and Jordyn Hernandez - HHOW announces grants for pediatric cancer research and COVID-19 drive-thru testing

Sentry Data Systems, Inc., the nation’s leader in pharmacy procurement, compliance and utilization management, announced today the release of Reclaim Rx™, a solution enabling 340B safety-net providers to remain compliant with new processes imposed by certain pharmaceutical manufacturers.

BioNTech SE announced the pricing of its previously announced underwritten offering and terms of its previously announced rights offering.

On July 22 , the National Spine Health Foundation launches our new, free, patient education program, Spine-Talks® Cities 2020 which can be viewed by visiting www.spine-talks.org . From San Diego to New York and more cities in between, Spine-Talks® Cities 2020 is a virtual tour with some of the nation’s top spine surgeons

100% of clinical leaders see need for change as manual processes delay study activation

Kubota Vision Inc. (Kubota Vision), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), today announced that the company and The Research Foundation for the State University of New York (Foundation) have entered into a research agreement to conduct and carry out the testing and characterization of our investigational, wearable myopia-control device based on